Clinical research - Press Releases

Date	Title	Company
27-Jun-2023	DIPHARMA AND LOGIXX PHARMA ANNOUNCE GRANTING OF MARKETING AUTHORISATION APPROVAL FOR GENERIC SAPROPTERIN IN UNITED KINGDOM	Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”)
27-Jun-2023	Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation	University of Eastern Finland
27-Jun-2023	Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
27-Jun-2023	Researchers highlight flaws in COVID-19 weather studies and call for improved publishing practices	The University of Manchester
27-Jun-2023	Immodulon Further Strengthens Leadership Team with the Appointments of Richard Couch as Chief Technology Officer and Owen Vaughan as Chief Regulatory Officer	Immodulon Therapeutics Ltd
27-Jun-2023	Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform	Astraveus SAS
27-Jun-2023	Cresset Creates New Vice President Role to Lead their Discovery CRO Business	Cresset
27-Jun-2023	Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-INAD Program	Bloomsbury Genetic Therapies Limited
27-Jun-2023	New report from The King’s Fund shows the UK underperforming on treatable health conditions, says the ABPI	ABPI
27-Jun-2023	Researchers reveal mechanism of protection against breast and ovarian cancer	Francis Crick Institute
23-Jun-2023	Molecure files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study	Molecure S.A
23-Jun-2023	Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B	Vaccitech
23-Jun-2023	EXPERIENCING BRAIN FOG? HERE ARE THE TOP BRAIN-BOOSTING FOODS FOR A SHARP MIND AND THE ONE THING YOU SHOULDN’T EAT ACCORDING TO A BRAIN HEALTH NUTRITIONAL THERAPIST	Cytoplan
23-Jun-2023	PRESS RELEASE IRBM Extends Peptide Therapeutics Collaboration with Merck & Co. Inc. Rahway NJ USA	IRBM
22-Jun-2023	Poolbeg Pharma Plc Oral Vaccine Programme Moves Forward	Poolbeg Pharma Plc
22-Jun-2023	PSYCH Symposium 2023: Unlocking the potential of psychedelic medicine on 6th July 2023	PSYCH Symposium
22-Jun-2023	Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis	Imcyse
22-Jun-2023	Birmingham research contributes to World Rugby’s international player welfare campaign	University of Birmingham
22-Jun-2023	Alchemab Therapeutics unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium	Alchemab Therapeutics
22-Jun-2023	The UK must start universal screening for three common genetic conditions at age 30, says expert	US medical journal